Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cerebrospinal fluid ferritin-Unspecific and unsuitable for disease monitoring.
Gender influence on schizophrenia-relevant abnormalities in a cuprizone demyelination model.
Is malnutrition a problem for multiple sclerosis patients?
[New aspects in the therapy of multiple sclerosis and optic neuritis.]
An exploration of impaired walking dynamics and fatigue in Multiple Sclerosis.
Serum ethanolamine plasmalogens improve detection of cognitive impairment among elderly with high excretion levels of urinary myo-inositol: A cross-sectional study.
Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: A preliminary study.
Large-scale neuronal network dysfunction in relapsing-remitting multiple sclerosis.
The feasibility and short-term benefits of Blue Prescription: a novel intervention to enable physical activity for people with multiple sclerosis.
[Antidepressants for treatment of depression in palliative patients : A systematic literature review.]
Bochum ultrasound score versus clinical and electrophysiological parameters in distinguishing acute-onset chronic from acute inflammatory demyelinating polyneuropathy.
Generating induced pluripotent stem cells for multiple sclerosis therapy.
A randomised controlled trial of an exercise plus behaviour change intervention in people with multiple sclerosis: the step it up study protocol.
Extensive acute axonal damage in pediatric multiple sclerosis lesions.
Antivirus immune activity in multiple sclerosis correlates with MRI activity.
Assessing risks of multiple sclerosis therapies.
Menopause in multiple sclerosis: therapeutic considerations.
Circulating CD56(dim) NK cells expressing perforin are increased in progressive multiple sclerosis.
Systematic review of occupational therapy-related interventions for people with multiple sclerosis: part 1. Activity and participation.
Interferon-beta-1a treatment has a positive effect on quality of life of relapsing-remitting multiple sclerosis: Results from a longitudinal study.
Processes of plasma protein N-homocysteinylation in multiple sclerosis.
The use of immune modulating drugs for the treatment of multiple sclerosis.
Mode of action and clinical studies with fumarates in multiple sclerosis.
Methods for identifying subject-specific abnormalities in neuroimaging data.
Brain glycolipids suppress T helper cells and inhibit autoimmune demyelination.

Pages